P value interpretation metabolomics

p-value-interpretation-metabolomics

License: restricted — no clear open-source license detected for the underlying tool; verify licensing before commercial use or redistribution. <!-- asb-license-banner -->

Summary

Interpret p-values from repeated measures ANOVA applied to imputed metabolomics trajectories to identify and rank metabolites by statistical significance. This skill bridges model output to feature prioritization in longitudinal metabolomic studies.

When to use

After fitting repeated measures ANOVA models to long-format imputed metabolomics data with a grouping variable (e.g., treatment, disease state) and subject-level random effects. Use this skill when you have p-values and F-statistics from ANOVA tests on individual metabolites and need to rank them by evidence of between-group difference to support downstream feature selection.

When NOT to use

• Input is already a feature table with pre-selected metabolites; this skill is for ranking, not post-hoc refinement.
• ANOVA assumptions are violated (e.g., non-normal residuals, heterogeneous variances); consider non-parametric alternatives such as Friedman test.
• Sample size per group is very small (n < 3–5 per group); p-values may be unreliable due to low statistical power.

Inputs

• Long-format imputed metabolomics dataset with columns: id (subject identifier), time (measurement timepoint), grouping variable (categorical), metabolite name, and numeric metabolite abundance values
• Repeated measures ANOVA model output containing F-statistics and p-values for each metabolite

Outputs

• Ranked feature table (CSV) with columns: metabolite name, F-statistic, p-value, rank
• Prioritized metabolite list for downstream statistical or pathway analysis

How to apply

Extract the p-value for each metabolite from the repeated measures ANOVA model output (fixed effect test for the grouping variable). Sort metabolites in ascending order by p-value (or equivalently, descending by F-statistic) to rank by statistical significance. Apply a significance threshold (commonly α = 0.05) to identify metabolites with strong evidence of difference across groups. Document the ranking with metabolite name, F-statistic, p-value, and rank position in a tabular format. The rationale is that lower p-values indicate stronger evidence against the null hypothesis of no group difference, making them candidates for prioritization in feature selection and subsequent pathway or biomarker analysis.

Related tools

• MeTEor (R Shiny application implementing repeated measures ANOVA and statistical model output for metabolomics; generates p-values and F-statistics used for p-value interpretation and metabolite ranking) — https://github.com/scibiome/meteor
• R (Programming language for extracting, sorting, and tabulating p-values and F-statistics from ANOVA model objects)
• tidyverse (R package suite for data manipulation and ranking of ANOVA results by p-value)

Evaluation signals

• Ranked feature table is non-empty and sorted in ascending order by p-value (or descending by F-statistic); spot-check the first and last entries.
• All p-values in output range from 0 to 1 and metabolites are unique (no duplicates).
• Metabolites with p-value < 0.05 appear at the top of the rank; those with p > 0.05 appear lower.
• The number of ranked metabolites matches the number of unique metabolites in the input ANOVA output.
• Summary statistics (e.g., number of significant metabolites at α = 0.05) are consistent with the p-value distribution and total metabolite count.

Limitations

• p-value interpretation assumes ANOVA model assumptions are met (normality of residuals, sphericity, homogeneity of variance); violations can inflate false positive or false negative rates.
• p-values reflect statistical significance, not biological effect size or magnitude; a small p-value does not guarantee large or clinically meaningful metabolite changes.
• Multiple comparisons across many metabolites increase family-wise error rate; consider applying multiple testing correction (e.g., Bonferroni, FDR) if not already applied upstream.
• Ranking by p-value alone does not account for metabolite stability, measurement variability, or biological plausibility; should be combined with effect size and domain knowledge.

Evidence

• [other] For each metabolite, fit a repeated measures ANOVA model with the grouping variable as the fixed effect and id as the random effect (subject). Extract the F-statistic and p-value for each metabolite from the ANOVA output.: "For each metabolite, fit a repeated measures ANOVA model with the grouping variable as the fixed effect and id as the random effect (subject). Extract the F-statistic and p-value for each metabolite"
• [other] Rank all metabolites by p-value (ascending) or F-statistic (descending) to prioritize those with strongest evidence of difference across groups.: "Rank all metabolites by p-value (ascending) or F-statistic (descending) to prioritize those with strongest evidence of difference across groups."
• [other] Export the ranked feature table as a CSV file with columns: metabolite name, F-statistic, p-value, and rank.: "Export the ranked feature table as a CSV file with columns: metabolite name, F-statistic, p-value, and rank."
• [readme] Statistical models: Linear Mixed Models, Repeated Measures ANOVA, Mixed ANOVA, Friedman test: "Statistical models: Linear Mixed Models, Repeated Measures ANOVA, Mixed ANOVA, Friedman test"